Navigation Links
Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care

ORANGE COUNTY, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), announced today that it has signed new sole source agreements with Adventist Health to provide a broad range of core laboratory systems and supplies valued at approximately $36 million over six years. Adventist Health is a not-for-profit, faith-based health care system with facilities in California, Hawaii, Oregon, and Washington.


Under the terms of the new six-year agreements, Adventist Health hospital laboratories will continue to purchase hematology products from Beckman Coulter, and will add the company's complete line of automated chemistry and immunoassay analyzers and reagents to their owned, leased and managed facilities. An expanding group of more than 38 acute-care affiliate organizations will also be able to purchase systems under the contract.

In making the decision, Adventist Health cited Beckman Coulter's ability to deliver cutting-edge technologies that can help their physicians deliver prompt and effective patient care. Lowell Church, assistant vice president, said, "We are constantly striving to enhance quality care, increase patient safety and improve outcomes, in addition to controlling costs. Beckman Coulter has the same vision and goals and we look forward to collaborating with them."

David Bespalko, corporate vice president of sales in North America for Beckman Coulter, said about the contract, "These agreements are a great opportunity to continue to demonstrate our commitment to improving patient health and reducing the cost of care. Our innovative systems simplify and automate laboratory processes, helping to improve the efficiency of our laboratory partners."

About Adventist Health.

Adventist Health is a faith-based, not-for-profit health care system with headquarters in Roseville, California and more than 18,000 employees. The system has operations in California, Hawaii, Oregon, and Washington, including 18 acute care facilities; numerous clinics and outpatient facilities, including the largest network of rural health clinics in California; 15 home care agencies; and three joint-venture retirement centers. To learn more, visit

About Beckman Coulter, Inc.

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company's 2007 annual revenue of $2.76 billion. For more information, visit

Contacts: Mary Luthy, Beckman Coulter Allan Harris, Beckman Coulter

Corporate Communications Investor Relations

(714) 773-7964 (714) 773-7620

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
2. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
3. Beckman Coulter Investor Events Second Half of 2008
4. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
5. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
6. Beckman Coulter Announces Second Quarter 2008 Results
7. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
8. Upcoming Beckman Coulter Investor Events Second Half of 2008
9. Beckman Coulter to Present at Upcoming Healthcare Conferences
10. Beckman Coulter Announces First Quarter 2008 Results
11. Beckman Coulter Acquires Rights to Hepatitis C Virus
Post Your Comments:
(Date:6/27/2016)... June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" ... by its major shareholders, Clean Technology Fund I, LP ... States based venture capital funds which together ... (on a fully diluted, as converted basis), that they ... their entire equity holdings in Biorem to TUS Holdings ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):